Drug-labels.com

Priva-Ezetimibe: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
10 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Priva-Ezetimibe

What it does:

PRIVA-EZETIMIBE works by decreasing the absorption of cholesterol in the small intestine.

When it should not be used:

  • Patients who are hypersensitive (allergic) to ezetimibe or any of the nonmedicinal ingredients should not take PRIVA-EZETIMIBE
  • Patients with liver disease, active or unexplained increases in liver enzymes (blood tests of liver function) should not take PRIVA-EZETIMIBE together with a statin.
  • Patients who are pregnant should not take PRIVA-

    EZETIMIBE together with a statin.

  • Patients who are nursing should not take PRIVA-

    EZETIMIBE together with a statin.

What the medicinal ingredient is:

Ezetimibe.

What the important nonmedicinal ingredients are: Lactose monohydrate, Croscarmellose sodium, Sodium lauryl sulphate, Hypromellose, Colloidal silicon dioxide, Microcrystalline cellulose, Hydrogenated castor oil, Sodium stearyl fumarate.

What dosage forms it comes in:

Tablet 10 mg (white to off-white).

Before you use PRIVA-EZETIMIBE talk to your doctor if you:

  • are pregnant, plan to become pregnant or think you might be pregnant.
  • are breast-feeding. PRIVA-EZETIMIBE may be passed in your milk to your baby.
  • have now or have had in the past any medical problems (including liver disease or liver problems).

You should always tell your doctor about all drugs that you are taking or plan to take as well as those obtained without a prescription.

Drugs that may interact with PRIVA-EZETIMIBE include:

ABOUT THIS MEDICATION

What the medication is used for:

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

  • Liver disease (Hepatitis)
  • Pancreas disease (Pancreatitis)
  • Muscle pain (Myopathy/Rhabdomyolysis, myalgia)
  • Severe allergic reaction (Anaphylaxis)

INTERACTIONS WITH THIS MEDICATION

  • Cyclosporine
  • Cholestyramine (a resin/bile acid sequestrant) or any other bile acid sequestrant. In that case, PRIVA-EZETIMIBE should be taken at least 2 hours before or 4 hours after taking the bile acid sequestrant.
  • Fibrates

Usual dose:

  • PRIVA-EZETIMIBE should be taken as directed. Take

    one 10 mg tablet by mouth each day, preferably at the same time of day. PRIVA-EZETIMIBE can be taken with or without food.

  • Continue taking your other cholesterol-lowering

    medicines known as statins or fenofibrate unless your doctor tells you to stop.

  • If you are taking a statin or fenofibrate, PRIVA-

    EZETIMIBE can be taken at the same time.

  • Even if you are taking medication to treat high

    cholesterol, it is important to have your cholesterol measured regularly. You should also know your cholesterol levels and goals.

Overdose:

Take PRIVA-EZETIMIBE only as prescribed for you. If you take more PRIVA-EZETIMIBE than you were prescribed, contact your doctor or pharmacist.

pain (myalgia); back pain; throat infection (pharyngitis); nose infection (sinusitis); upper chest infection (respiratory tract); and changes in certain laboratory blood tests.

The following uncommon side effects have been reported: tingling sensation; dry mouth; gastritis; itching; rash; hives; muscular weakness; pain in arms and legs; unusual tiredness or weakness; and swelling, especially in the hands and feet.

When used with fenofibrate, the following side effect was reported: abdominal pain

  • In general use, the following side effects have been reported: raised red rash, sometimes with target-shaped lesions; dizziness; depression; tingling sensation; constipation; and unusual tiredness or weakness
  • You should contact your doctor if you develop persistent and severe muscle aches or pains with no obvious explanation at any time after starting to take PRIVA-EZETIMIBE.

If you are prescribed PRIVA-EZETIMIBE with a statin, your doctor will order routine blood tests to check your liver function before and after starting treatment.

Talk to your doctor anytime you have a medical problem you think may be related to PRIVA-EZETIMIBE.

Missed dose:

If you miss a dose, just resume the usual schedule of one tablet daily.

Ezetimibe is generally well tolerated.

  • When used alone, the following common side effects have

    been reported: abdominal pain; diarrhea; flatulence; tiredness; viral infection; throat infection (pharyngitis); nose infection (sinusitis); joint pain (arthralgia); back pain; and coughing.

    The following uncommon side effects have been reported: elevations in some laboratory blood tests of liver (transaminases) or muscle (CK) function; indigestion; heartburn; nausea; muscle spasms; neck pain; decreased appetite; hot flush; high blood pressure; chest pain and pain

    • When used with a statin, the following common side

      effects have been reported: headache; tiredness; abdominal pain; diarrhea; joint pain (arthralgia); muscle In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO ABOUT THEM

PROPER USE OF THIS MEDICATION

You may obtain further information from your doctor or pharmacist.

This is not a complete list of side effects. For any unexpected effects while taking PRIVA-EZETIMIBE, contact your doctor or pharmacist.

This document plus the full product monograph, prepared for health professionals by Nora Pharma Inc., 1565 Lionel-Boulet Boul., Varennes, Quebec, J3X 1P7.

Phone: 1-888-270-9874

Date of revision: June 15, 2022

Keep your medicine between 15°C and 30°C. Protect from moisture.

Keep PRIVA-EZETIMIBE and all medicines out of the reach of children. Do not use this medicine after the date shown following EX (or EXP) on the container.

IMPORTANT: PLEASE READ

HOW TO STORE IT

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or o Mail to:

      Canada Vigilance Program

      Health Canada

      Postal Locator 0701E

      Ottawa, Ontario

      K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at:

www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of the side effect, contact your health professional. The Canada Vigilance Program do not provide medical advice.

WHAT TO DO ABOUT THEM
Symptoms / effects

Talk with your doctor or

pharmacist

Stop taking drug and seek

immediate emergency medical

attention.

Only if severeIn all cases
Rare

Muscle aches and pains (Myopathy/

Rhabdomyolysis)

✓
Sudden severe allergic reactions (swelling of the face, lips, tongue, and/or throat that may cause difficulty in breathing or swallowing, rash and hives).✓

Symptoms of liver

problems (severe

abdominal pain, especially if felt on the upper right side below the ribs, dark urine, general itchiness, severe nausea or vomiting, pale stools, yellowing of skin or eyes)

✓

Symptoms of gallstones or inflammation of the

gallbladder (severe

abdominal pain, nausea, vomiting)

✓

MORE INFORMATION

Symptoms of pancreas problems (severe abdominal pain)✓

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02425238

Revision date stated in the text: June 15, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Priva-Ezetimibe

Rx or OTC
Prescription (Rx)?
DIN 02425238
Schedule(s) PRESCRIPTION
Active ingredient(s) Ezetimibe 10 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AX Other lipid modifying agents
          1. C10AX09 Ezetimibe
Company NORA PHARMA INC
Current status Cancelled Post Market
Current status date July 25, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.